The mRNA expression of VCAM-1 and ICAM-1 was increased in UUO- or AD-treated kidneys, but SAMiRNA-AREG treatment significantly reduced their expression (Fig. 6c,d). This evidence concerns the gene ICAM1 and Alzheimer disease.